Candida bloodstream infection in left ventricular assist device recipients: Case series and review of the literature.

Candida bloodstream infection occurs in approximately 3% of LVAD patients and results in a 62.5% mortality rate, highlighting its severity in this population.

• Why it matters: Understanding C-BSI in LVAD recipients is crucial because it is a rare but often fatal complication with limited existing data, hindering effective prevention and management strategies.
• What they did: A retrospective review of 24 cases from our institution and literature, analyzing clinical features, timing, species involved, and outcomes, including risk factors like obesity and right heart failure.
• The result: The findings reveal high complication and mortality rates, emphasizing the need for vigilant monitoring and tailored interventions to improve survival in LVAD patients with C-BSI.